Skip to main content

Jasper Therapeutics, Inc.

JSPR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001788028

No open-market purchases or sales by Jasper Therapeutics, Inc. insiders were filed in the last 90 days; 45 institutions reported holding it in 13F filings for Q2 2026, worth $5.05M in total; no superinvestor holds it.

Other share classesJSPRW

13F holders, Q3 2024

Institutional positions in Jasper Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
81
+13 vs. Q2 2024
Shares held
14.7M
+812.9K (+5.9%) vs. Q2 2024
Total value
$274.8M
−$39.3M (−12.5%) vs. Q2 2024
New holders
25
22 more added
Sold out
12
20 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting JSPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 81 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 9 institutionsQ4 2021: 25 institutionsQ1 2022: 24 institutionsQ2 2022: 23 institutionsQ3 2022: 23 institutionsQ4 2022: 23 institutionsQ1 2023: 45 institutionsQ2 2023: 46 institutionsQ3 2023: 41 institutionsQ4 2023: 42 institutionsQ1 2024: 61 institutionsQ2 2024: 69 institutionsQ3 2024: 81 institutionsQ4 2024: 88 institutionsQ1 2025: 69 institutionsQ2 2025: 65 institutionsQ3 2025: 60 institutionsQ4 2025: 55 institutionsQ1 2026: 58 institutionsQ2 2026: 45 institutions
Value heldQ3 2024: $274.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $101.4MQ4 2021: $160.7MQ1 2022: $69.6MQ2 2022: $37.5MQ3 2022: $15.7MQ4 2022: $9.57MQ1 2023: $168.8MQ2 2023: $120.0MQ3 2023: $63.7MQ4 2023: $61.2MQ1 2024: $380.2MQ2 2024: $329.8MQ3 2024: $274.8MQ4 2024: $334.5MQ1 2025: $56.1MQ2 2025: $69.5MQ3 2025: $47.8MQ4 2025: $35.2MQ1 2026: $13.9MQ2 2026: $5.05M
Institutions holding JSPR and their total value by quarter
QuarterHoldersValue
Q2 202645$5.05M
Q1 202658$13.9M
Q4 202555$35.2M
Q3 202560$47.8M
Q2 202565$69.5M
Q1 202569$56.1M
Q4 202488$334.5M
Q3 202481$274.8M
Q2 202469$329.8M
Q1 202461$380.2M
Q4 202342$61.2M
Q3 202341$63.7M
Q2 202346$120.0M
Q1 202345$168.8M
Q4 202223$9.57M
Q3 202223$15.7M
Q2 202223$37.5M
Q1 202224$69.6M
Q4 202125$160.7M
Q3 20219$101.4M
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Jasper Therapeutics, Inc.; share changes are against Q2 2024.

Institutions holding JSPR in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Velan Capital Investment Management LP1,433,828$27.0M29.28%−38,076−2.6%Reduced
Soleus Capital Management, L.P.1,343,665$25.3M2.10%+67,475+5.3%Added
Carlyle Group Inc.1,066,189$19.9M2.09%00.0%Unchanged
Qiming U.S. Ventures Management, LLC928,964$17.5M34.02%00.0%Unchanged
BlackRock, Inc.800,028$15.0M0.00%+800,028New
Vanguard Group Inc694,425$13.1M0.00%+4,366+0.6%Added
Samsara BioCapital, LLC584,642$11.0M2.11%+59,642+11.4%Added
Polar Capital Holdings Plc581,538$10.9M0.06%00.0%Unchanged
Morgan Stanley565,722$10.6M0.00%+256,303+82.8%Added
Franklin Resources Inc579,636$9.61M0.00%−118,900−17.0%Reduced
Kingdon Capital Management, L.L.C.497,000$9.35M1.37%00.0%Unchanged
Woodline Partners LP495,104$9.31M0.08%+81,164+19.6%Added
Braidwell LP483,300$9.09M0.26%+483,300New
Rock Springs Capital Management LP459,088$8.64M0.28%+54,753+13.5%Added
Ally Bridge Group (NY) LLC399,466$7.51M4.02%+180,852+82.7%Added
Opaleye Management Inc.353,500$6.65M1.11%−38,500−9.8%Reduced
Boxer Capital, LLC350,000$6.58M0.32%00.0%Unchanged
Integral Health Asset Management, LLC350,000$6.58M0.78%+350,000New
Bank of America Corp325,881$6.13M0.00%+557+0.2%Added
Great Point Partners LLC322,380$6.06M1.83%−79,635−19.8%Reduced
Geode Capital Management, LLC257,416$4.84M0.00%−2,338−0.9%Reduced
State Street Corp214,883$4.04M0.00%+23,564+12.3%Added
Russell Investments Group, Ltd.211,526$3.98M0.01%+70,039+49.5%Added
Sphera Funds Management Ltd.189,270$3.56M0.58%−264,957−58.3%Reduced
Citadel Advisors LLC141,564$2.66M0.00%+141,564New
Deutsche Bank AG131,259$2.47M0.00%−63,176−32.5%Reduced
Northern Trust Corp106,940$2.01M0.00%+77,641+265.0%Added
Nuveen Asset Management, LLC83,417$1.57M0.00%+62,736+303.4%Added
Marshall Wace, LLP66,325$1.25M0.00%+66,325New
Goldman Sachs Group Inc55,765$1.05M0.00%+19,564+54.0%Added
Ikarian Capital, LLC55,175$1.04M0.32%−50,000−47.5%Reduced
Fernwood Investment Management, LLC52,897$995.0K0.32%+3,427+6.9%Added
Mariner, LLC42,206$793.9K0.00%−5,122−10.8%Reduced
FMR LLC38,361$721.6K0.00%+38,361New
Dimensional Fund Advisors LP36,925$694.6K0.00%+36,925New
Charles Schwab Investment Management Inc32,407$609.6K0.00%00.0%Unchanged
Lion Point Capital, LP32,000$601.9K2.41%00.0%Unchanged
Verition Fund Management LLC25,353$476.9K0.00%+25,353New
Bank of New York Mellon Corp24,030$452.0K0.00%−8,549−26.2%Reduced
Wellington Management Group LLP23,759$446.9K0.00%+23,759New
Susquehanna International Group, LLP20,520$386.0K0.00%+20,520New
AlphaCentric Advisors LLC17,500$329.2K0.24%+17,500New
American Century Companies Inc16,806$316.1K0.00%+2,602+18.3%Added
JPMorgan Chase & Co16,391$308.3K0.00%+11,567+239.8%Added
Barclays PLC16,146$303.7K0.00%+12,308+320.7%Added
ADAR1 Capital Management, LLC15,816$297.5K0.05%+15,816New
Balyasny Asset Management LLC14,743$277.3K0.00%+14,743New
Jane Street Group, LLC13,354$251.2K0.00%+13,354New
Rhumbline Advisers13,109$246.6K0.00%−122−0.9%Reduced
Boothbay Fund Management, LLC12,236$230.2K0.01%−11,088−47.5%Reduced
NEOS Investment Management LLC11,219$211.0K0.01%+11,219New
Shay Capital LLC10,000$188.1K0.06%−6,357−38.9%Reduced
Citigroup Inc8,165$153.6K0.00%+5,702+231.5%Added
Leonteq Securities AG8,000$150.5K0.02%00.0%Unchanged
MetLife Investment Management6,874$129.3K0.00%+3,873+129.1%Added
Mirae Asset Global ETFs Holdings Ltd.6,212$116.8K0.00%+6,212New
Corebridge Financial, Inc.6,053$113.9K0.00%−37−0.6%Reduced
UBS Group AG5,317$100.0K0.00%+1,265+31.2%Added
LMR Partners LLP5,274$99.2K0.00%−34,554−86.8%Reduced
New York State Common Retirement Fund4,600$86.5K0.00%00.0%Unchanged
Wells Fargo & Company3,587$67.5K0.00%−138−3.7%Reduced
Wolff Wiese Magana LLC3,146$59.2K0.04%+3,146New
BNP Paribas Arbitrage, SA2,512$47.3K0.00%+1,698+208.6%Added
STRS Ohio2,100$39.5K0.00%00.0%Unchanged
Royal Bank of Canada1,549$29.0K0.00%+484+45.4%Added
Simplex Trading, LLC1,354$25.0K0.00%−4,467−76.7%Reduced
Legal & General Group Plc1,213$22.8K0.00%−42−3.3%Reduced
Ameritas Investment Partners, Inc.1,109$20.9K0.00%00.0%Unchanged
Acadian Asset Management LLC930$17.0K0.00%+930New
Advisor Group Holdings, Inc.837$15.7K0.00%00.0%Unchanged
California State Teachers Retirement System820$15.4K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)695$13.1K0.00%+695New
US Bancorp512$9.63K0.00%+512New
Amalgamated Bank392$7.00K0.00%00.0%Unchanged
Sterling Capital Management LLC12$2260.00%+12New
Signaturefd, LLC11$2070.00%+11New
Nisa Investment Advisors, LLC5$940.00%+5New
Danske Bank A/S2$380.00%+2New
National Bank of Canada1$190.00%−99−99.0%Reduced
Lazard Asset Management LLC17$00.00%−31−64.6%Reduced
CWM, LLC15$00.00%+15New
Avidity Partners Management LP0$00.00%−782,000−100.0%Sold out
Octagon Capital Advisors LP0$00.00%−287,500−100.0%Sold out
StemPoint Capital LP0$00.00%−143,775−100.0%Sold out
Silverarc Capital Management, LLC0$00.00%−109,892−100.0%Sold out
Cantor Fitzgerald, L. P.0$00.00%−61,603−100.0%Sold out
Walleye Capital LLC0$00.00%−52,669−100.0%Sold out
Millennium Management LLC0$00.00%−22,990−100.0%Sold out
EAM Investors, LLC0$00.00%−21,525−100.0%Sold out
Bamco Inc0$00.00%−20,000−100.0%Sold out
Invesco Ltd.0$00.00%−19,121−100.0%Sold out
Alpine Global Management, LLC0$00.00%−10,719−100.0%Sold out
Quarry LP0$00.00%−1,000−100.0%Sold out
BlackRock Inc.––––Not filed